Pruritus in cholestatic and other liver diseases
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Summary: Pruritus is often the most troublesome symptom in patients with chronic liver disease, particularly when cholestasis is a prominent feature. The exact pathogenesis is unknown, but empirical treatment, such as cholestyramine, based on a liver‐based origin of pruritus, has been used for many years. Recently, evidence for a central mechanism for pruritus has been obtained and opioid antagonists have been tried clinically with some benefit, but their use is not widespread. In addition, the pruritus associated with intrahepatic cholestasis of pregnancy can now be alleviated in many cases by ursodeoxycholic acid. As it also improves foetal outcome, this should become first‐line therapy. We review the pathogenesis and therapy of pruritus, highlighting practical aspects to help with patients with seemingly intractable pruritus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755
Bergasa, N. V., Alling, D. W., Talbot, T. L., Swain, M. G., Yurdaydin, C., Turner, M. L., Schmitt, J. M., Walker, E. C., & Jones, E. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-3-199508010-00001 · Cited by 365
Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
Wolfhagen, F., Sternieri, E., Hop, W., Vitale, G., Bertolotti, M., & Van Buuren, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322521 · Cited by 343
Goulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315
Self-citationA controlled trial of naloxone infusions for the pruritus of chronic cholestasis
Bergasa, N. V., Talbot, T. L., Alling, D. W., Schmitt, J. M., Walker, E. C., Baker, B. L., Korenman, J. C., Park, Y., Hoofnagle, J. H., & Jones, E. A. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90102-5 · Cited by 287
Treatment of pruritus of primary biliary cirrhosis with rifampin
Podesta, A., Lopez, P., Terg, R., Villamil, F., Flores, D., Mastai, R., Udaondo, C. B., & Companc, J. P. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01300759 · Cited by 267
Treatment of pruritus in primary biliary cirrhosis with rifampin
Ghent, C. N., & Carruthers, S. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90442-8 · Cited by 257
Effects of long-term rifampicin administration in primary biliary cirrhosis
Bachs, L., Parés, A., Elena, M., Piera, C., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90335-v · Cited by 235
COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSIS
Bachs, L., Elena, M., Parés, A., Piera, C., & Rodés, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91608-5 · Cited by 231
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002) · Gut · doi:10.1136/gut.50.3.436 · Cited by 202
Research works printed but not linked: 106
- 10.1001/archderm.1957.01550210020004 · DOI · Paper page
- 10.1038/82924 · DOI · Paper page
- 10.1136/bmj.284.6321.1015 · doi:10.1136/bmj.284.6321.1015
- 10.1016/0304-3959(88)90085-1 · DOI · Paper page
- 10.1038/82956 · DOI
- 10.1016/S0016-5085(19)31870-0 · DOI · Paper page
- 10.1001/archderm.1974.01630050024005 · doi:10.1001/archderm.1974.01630050024005
- Varco RL., 1947, Intermittent external biliary drainage for the relief of pruritus in certain chronic disorders of the liver, Surgery, 21, 43
- Huet PM, 1970, The effects of biliary drainage in cholestatic hepatitis, Rev Med Chir Foie, 45, 271
- 10.1053/jhep.2002.33332 · DOI
- 10.1042/cs0630065 · DOI
- 10.1136/gut.51.5.756 · DOI
- 10.1111/j.1365-2141.1975.tb02753.x · DOI
- 10.1136/bmj.1.6063.752 · doi:10.1136/bmj.1.6063.752
- 10.1097/00000441-196507000-00009 · DOI
- Ghent CN., 1987, Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin, Am J Gastroenterol, 82, 117
- 10.1016/0016-5085(95)90709-2 · DOI
- 10.1001/archderm.1948.01520180045006 · DOI · Paper page
- 10.1136/pgmj.58.683.531 · doi:10.1136/pgmj.58.683.531
- 10.1136/bmj.297.6662.1501 · DOI · Paper page
- 10.1016/0016-5085(92)90857-U · DOI · Paper page
- 10.1016/S0168-8278(05)80471-4 · DOI
- 10.1016/0168-8278(92)90040-V · DOI
- Spivey JR, 1992, Serum met‐enkephalin levels in patients with primary biliary cirrhosis correlate with severity of disease but not pruritus, Gastroenterology, 102, 892A
- 10.1111/j.1749-6632.1990.tb16906.x · DOI
- 10.1002/j.1875-9114.1996.tb03015.x · DOI
- 10.1111/j.1365-2044.1996.tb07718.x · DOI
- Talbot TL, 1991, Application of piezo film technology for the quantitative assessment of pruritus, Biomed Instrum Technol, 25, 400
- 10.1007/BF02510746 · DOI
- 10.1017/S0033291700009934 · DOI · Paper page
- Hadzigiannis S, 1989, A randomised controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC), Hepatology, 10, 580A
- Matsuzaki Y, 1990, Improvement of biliary enzyme levels and itching as a result of long‐term administration of ursodeoxycholic acid in primary biliary cirrhosis, Am J Gastroenterol, 85, 15
- 10.1016/S0168-8278(05)80214-4 · DOI
- 10.1016/S0168-8278(00)80216-0 · DOI · Paper page
- 10.1016/0016-5085(95)90696-7 · DOI
- Gluud C, 2002, Ursodeoxycholic acid for primary biliary cirrhosis, Cochrane Database Syst Rev, 1, CD000551
- 10.1016/0168-8278(92)90065-W · DOI · Paper page
- 10.1056/NEJM199005173222003 · DOI · Paper page
- 10.1016/0016-5085(91)90085-Y · DOI
- 10.1016/S0016-5085(99)70403-8 · DOI
- 10.1053/gast.1999.0029900400 · DOI
- 10.1016/0016-5085(94)90085-X · DOI
- 10.1136/gut.16.2.93 · DOI
- 10.1136/bmj.1.5325.216 · DOI
- 10.1111/j.1445-5994.1984.tb05023.x · doi:10.1111/j.1445-5994.1984.tb05023.x
- Shojania AM, 1986, Hypoprothrombinemic hemorrhage due to cholestyramine therapy., CMAJ, 134, 609
- Shimada H, 1996, The interaction between MCI‐196 (colestimide) and bile acids or other biological substances, Jpn Pharmacol Ther, 24, 601
- Berg CI., 2001, Use of colesevalem hydrochloride (Welchol™) as a novel therapeutic agent for the management of refractory pruritus in chronic liver disease, Hepatology, 34, 541A
- Miguet JP, 1977, Induction of hepatic microsomal enzymes after brief administration of rifampicin in man, Gastroenterology, 72, 924, 10.1016/S0016-5085(77)80212-6 · DOI
- 10.1007/BF01308307 · DOI
- 10.1016/0016-5085(81)90709-5 · DOI
- 10.1097/00004836-199004000-00012 · DOI · Paper page
- 10.1016/0016-5085(90)90027-X · DOI
- 10.1056/NEJM197605132942008 · DOI · Paper page
- Bernstein JE, 1979, Relief of intractable pruritus with naloxone, Arch Dermatol, 115, 1366, 10.1001/archderm.1979.04010110058029 · doi:10.1001/archderm.1979.04010110058029 · Paper page
- 10.1097/00042737-200111000-00022 · DOI · Paper page
- Carson KL, 1996, Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease, Am J Gastroenterol, 91, 1022
- 10.1016/S0140-6736(86)91196-7 · DOI
- 10.1007/BF00184497 · DOI
- 10.1056/NEJM199405263302117 · DOI · Paper page
- 10.1016/0304-3959(94)00145-5 · DOI · Paper page
- 10.1097/00042737-199810000-00010 · DOI · Paper page
- Borgeat A, 1992, Propofol and cholestatic pruritus, Am J Gastroenterol, 87, 672
- 10.1016/0016-5085(93)90858-A · DOI
- Borgeat A, 1994, Pruritus associated with liver disease: Propofol, a new therapeutic approach?, Schweiz Med Wochenschr, 124, 649
- 10.1016/S0140-6736(80)91849-8 · DOI
- 10.1111/j.1365-2133.1987.tb05825.x · DOI · Paper page
- 10.1111/j.1572-0241.2001.03778.x · DOI
- 10.1002/hep.1840040217 · DOI · Paper page
- 10.1016/0016-5085(90)91250-A · DOI
- 10.1002/hep.1840130613 · DOI
- Everson GT, 1989, Benign recurrent intrahepatic cholestasis: treatment with S‐ adenosylmethionine, Gastroenterology, 96, 1354, 10.1016/S0016-5085(89)80024-1 · DOI
- 10.1016/S0022-2275(20)41965-0 · DOI
- 10.1002/hep.510260118 · DOI · Paper page
- 10.1046/j.1440-1746.1999.01968.x · DOI
- 10.1111/j.1572-0241.2002.05852.x · doi:10.1111/j.1572-0241.2002.05852.x · Paper page
- 10.1111/j.1346-8138.2000.tb02123.x · doi:10.1111/j.1346-8138.2000.tb02123.x
- 10.1111/j.1346-8138.2000.tb02217.x · doi:10.1111/j.1346-8138.2000.tb02217.x
- 10.1159/000051591 · doi:10.1159/000051591
- Lauterburg BH, 1978, Plasmaperfusion for the treatment of intractable pruritus of cholestasis, Mayo Clin Proc, 53, 403
- 10.1016/S0140-6736(80)92938-4 · DOI
- 10.1136/gut.26.3.291 · DOI · Paper page
- 10.1046/j.1525-1594.2002.06822.x · DOI · Paper page
- 10.1016/0016-5085(88)90301-0 · DOI · Paper page
- 10.1053/he.2000.5984 · DOI · Paper page
- Do Valle Gameiro MR, 2001, Pruritus in a patient with anicteric hepatitis: case report, Anais Brasil Dermatol, 76, 303
- 10.1136/gut.41.2.269 · DOI
- 10.1136/adc.69.1.141 · DOI
- 10.1023/A:1018865809556 · DOI
- 10.1023/A:1026646017851 · DOI
- 10.1023/A:1011925907102 · DOI
- 10.1016/S1590-8658(00)80847-6 · DOI
- Shaw D, 1982, A prospective study of 18 patients with cholestasis of pregnancy, Am J Obstet Gynecol, 142, 621, 10.1016/S0002-9378(16)32430-9 · doi:10.1016/s0002-9378(16)32430-9
- 10.1111/j.1471-0528.1992.tb14465.x · DOI
- 10.1002/hep.510280601 · DOI · Paper page
- 10.1002/hep.510260627 · DOI
- 10.1002/hep.1840150612 · DOI · Paper page
- 10.1016/0020-7292(95)02528-6 · doi:10.1016/0020-7292(95)02528-6
- 10.1016/S0168-8278(97)80146-8 · DOI · Paper page
- 10.1111/j.1471-0528.1998.tb09976.x · DOI
- 10.1080/jmf.10.2.131.135 · DOI
- 10.1016/0301-2115(96)02442-6 · DOI
- 10.1016/S0168-8278(98)80207-9 · DOI
- 10.1136/gut.37.4.580 · doi:10.1136/gut.37.4.580
- Burrows RF, 2001, Interventions for treating cholestasis in pregnancy, Cochrane Database Syst Rev, 4, CD000493
- 10.1136/bmj.324.7330.123 · DOI
Cited by
The TGR5 receptor mediates bile acid–induced itch and analgesia
Alemi, F., Kwon, E., Poole, D. P., Lieu, T., Lyo, V., Cattaruzza, F., Cevikbas, F., Steinhoff, M., Nassini, R., Materazzi, S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64551 · Cited by 378
Chapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284
Tandon, P., Rowe, B. H., Vandermeer, B., & Bain, V. G. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01200.x · Cited by 176
Kuiper, E. M. M., van Erpecum, K. J., Beuers, U., Hansen, B. E., Thio, B. H., de Man, R. A., Janssen, H. L. A., & van Buuren, H. R. (2010) · Hepatology · doi:10.1002/hep.23821 · Cited by 132
Rifai, K., Hafer, C., Rosenau, J., Athmann, C., Haller, H., Peter Manns, M., & Fliser, D. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520600610154 · Cited by 53
Metadata
- Authors
- Mela, M., Mancuso, A., & Burroughs, A. K.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2003-03-26
- Volume
- 17
- Issue
- 7
- Pages
- 857-870
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2077924643
- Cited by
- 129
- References
- 15
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pruritus in cholestatic and other liver diseases. https://app.cochat.ai/papers/10.1046/j.1365-2036.2003.01458.x
- The paper
- Mela, M., Mancuso, A., & Burroughs, A. K. (2003). Pruritus in cholestatic and other liver diseases. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2003.01458.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.